SOS: Systems of Support Study for Childhood Depression

Sponsor
Boston University Charles River Campus (Other)
Overall Status
Completed
CT.gov ID
NCT01159041
Collaborator
University of California, Los Angeles (Other), National Institute of Mental Health (NIMH) (NIH)
134
2
2
84
67
0.8

Study Details

Study Description

Brief Summary

This study is designed to compare two treatments for depression in pre-adolescent (7-13 year old) children. A family-focused treatment will be compared to an individual child-focused treatment in this 14-week intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Family Focused Treatment (FFT)
  • Behavioral: Individual Treatment (IP)
N/A

Detailed Description

Childhood-onset depression is an impairing and often recurrent and persistent disorder that impacts current and later development resulting in high personal, social, and economic costs. Despite the costs of early-onset depression, the emphasis in current practice parameters on an initial course of psychosocial treatment, and extensive research on adolescent depression, we currently lack randomized controlled trials evaluating psychosocial treatments for children with depressive disorders.

The present proposal aims to address this gap in knowledge regarding optimal psychosocial treatment strategies for children suffering from depressive disorders. We propose a 2-site randomized controlled trial to evaluate the efficacy of Family Focused Treatment (FFT), as compared to an individual client-centered psychotherapy (IP) modeled after "usual" community care. FFT adopts an interpersonal model for understanding how depressive symptoms are maintained, emphasizes developing family skills/strategies for altering interpersonal processes, and works on building a family environment that supports recovery and enhances stress resistance and resilience. This approach may be particularly appropriate to the developmental needs of depressed children, given their dependence on parents, the potential of FFT to address the needs of multiple family members, and our data supporting benefits on depression, functioning, and other co-occurring symptoms.

The proposed project will enroll 140 children (ages 8-12) with depressive disorders. Children will be randomly assigned to receive a 14-week trial of either FFT or IP. At study entry, immediately post-treatment, and at a 9-month post-treatment follow-up all participants will undergo intensive evaluation of clinical state and psychosocial and family functioning.

Study Design

Study Type:
Interventional
Actual Enrollment :
134 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Evaluation of Family Focused Treatment for Childhood Depression
Study Start Date :
Jan 1, 2010
Actual Primary Completion Date :
May 1, 2015
Actual Study Completion Date :
Dec 31, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Family Focused Treatment (FFT)

15 session family-based treatment emphasizing improving relationship skills to combat depression symptoms and support recovery.

Behavioral: Family Focused Treatment (FFT)
FFT is designed to specifically address the developmental needs of school-aged children and their parents through an emphasis on fostering positive and supportive parent-child interactions that scaffold the development of a positive self, to help parents provide the child additional positive feedback on his/her developmentally appropriate achievements, and to enhance family and child coping. This treatment is conducted with the child and his/her parent(s) and includes education about depression, communication training, relationship enhancement, and problem-solving.

Active Comparator: Individual Treatment (IP)

15 session individually-based treatment to assist children in understanding the causes of their symptoms.

Behavioral: Individual Treatment (IP)
The goals of the treatment are to foster the therapeutic relationship, to provide a supportive and empathic setting where the child can come to better understand his/her emotions/feelings and address issues underlying current symptoms. Therapeutic goals will be addressed through reflection and clarification of feelings/emotions and understanding the child's perception of the context of depressed feelings.

Outcome Measures

Primary Outcome Measures

  1. Adequate Depression Treatment Response [3 months]

    50% improvement on Children's Depression Rating Scale-Revised

Secondary Outcome Measures

  1. Interviewer-rated Depression Severity [3 Months]

    Children's Depression Rating Scale-Revised (CDRS-R) measures depression severity over the past two weeks. The 17-item CDRS-R has total scores ranging from 17 to 113 with scores of 40 or greater considered indicative of a depression diagnosis. Used in pharmacological and psychosocial treatment studies, it provides comparability across studies.

  2. Children's Self-Report of Depression Symptoms [3 Months]

    Child Depression Inventory (CDI) is a 27-item self-report measure. Scores range from 0 to 54 with higher scores reflecting higher levels of symptoms.

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 13 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • current Depressive Disorder

  • ages 7-13 years

  • living with at least one biological parent willing to participate

Exclusion Criteria:
  • thought disturbance

  • severe conduct disorders

  • unstable on antidepressant medications

  • continuation in current non-study treatment

  • non-English speaking

Contacts and Locations

Locations

Site City State Country Postal Code
1 UCLA Semel Institute for Neuroscience and Human Behavior Los Angeles California United States 90095
2 Boston University Boston Massachusetts United States 02215

Sponsors and Collaborators

  • Boston University Charles River Campus
  • University of California, Los Angeles
  • National Institute of Mental Health (NIMH)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Martha C. Tompson, Associate Professor, Boston University Charles River Campus
ClinicalTrials.gov Identifier:
NCT01159041
Other Study ID Numbers:
  • 1R01MH082861
  • R01MH082856-01A2
  • R01MH082861-01A2
First Posted:
Jul 9, 2010
Last Update Posted:
Jan 24, 2018
Last Verified:
Jan 1, 2018
Keywords provided by Martha C. Tompson, Associate Professor, Boston University Charles River Campus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 24, 2018